Cirrhosis News and Research

Latest Cirrhosis News and Research

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

One of the lines of research of the UPV/EHU's Lipids & Liver group, which focusses on the mechanisms involved in the development and progression of non-alcoholic fatty liver disease, is achieving significant advances in a range of aspects; these include the identification of proteins that alter the metabolic pathways in the development and progression of liver disease, and even cancer, and the seeking of targets to enable the disease to be reversed.

9 Jul 2018

Researchers develop inexpensive blood test to diagnose hepatitis B patients

A simple $20 blood test could help diagnose thousands of patients with hepatitis B in need of treatment in some of Africa's poorest regions.

2 Jul 2018

Chemical compounds produced by gut bacteria could help spot early stages of liver disease

Chemical compounds produced by the bacteria in our gut could be used to spot the early stages of liver disease, according to new research.

25 Jun 2018

Coffee and the heart – four strong cups a day is beneficial finds study

According to a new study four cups of strong coffee might be the amount that would keep the hearts of older adults healthy. The latest study titled, “CDKN1B/p27 is localized in mitochondria and improves respiration-dependent processes in the cardiovascular system—New mode of action for caffeine,” was published on 21st of June 2018 in the journal PLOS Biology.

25 Jun 2018

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

An estimated 3.5 million people in the United States have chronic hepatitis C (HCV), according to the Centers for Disease Control and Prevention.

18 Jun 2018

Ultrasound-based technology for assessing overweight adolescents with liver disease

Researchers from Charité - Universitätsmedizin Berlin have successfully tested a new technology for use in the assessment of overweight adolescents with liver disease.

18 Jun 2018

Video consultations boost survival rates of liver disease patients, study finds

For patients who live in rural areas, driving to see a specialist in a large city or at a university hospital can be challenging, if not impossible.

12 Jun 2018

Research shows that treating cholestasis in father lowers risk of high blood pressure in son

New research led by Professor Catherine Williamson, School of Life Course Sciences, shows that using drugs to treat male mice with cholestasis reduced the likelihood of male offspring developing high blood pressure.

11 Jun 2018

Changes to the immune system remain even after recovery from HCV infection, shows study

Changes to the immune system remain many years after a hepatitis C infection heals, a new study by researchers at Karolinska Institutet, Sweden, and Hannover Medical School, Germany, shows.

11 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018

Researchers gain new insights into hepatitis B virus

Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

4 Jun 2018

MiNA Therapeutics announces initial results from phase I trial of saRNA candidate in liver cancer patients

MiNA Therapeutics, the pioneer in RNA activation therapeutics, today announced preliminary results from its ongoing Phase I study of small activating RNA candidate MTL-CEBPA in advanced liver cancer.

4 Jun 2018

Researchers study effects of specific gut enterobacterium on body fat mass

A research project performed at the universities of Jyväskylä and Turku studied the effects of a specific gut enterobacterium on body fat mass.

1 Jun 2018

New mathematical model holds potential to improve treatment for Hepatitis C infection

The University of Surrey has created a new mathematical model that details how the Hepatitis C infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment for the infection that affects 215,000 people in the United Kingdom.

30 May 2018

Scientists develop lab-based system to study mechanisms of common liver disease

Scientists have developed a lab-based system for studying the most common type of liver disease, paving the way for research into new therapies.

23 May 2018

Scientists find how immune system helps to clear HBV infection after treatment interruption

Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption.

17 May 2018

Key metabolites shed by gut bacteria can help protect from inflammation, study finds

Researchers at Tufts University have elucidated a mechanism by which the "good" bacteria that reside in our gastrointestinal tract can help protect us from inflammation, and how their disruption (dysbiosis) can increase the susceptibility of the liver to more harmful forms of disease.

4 May 2018

Research shows prevalence, health-care utilization, and costs of alcohol-related cirrhosis

More than one-third of cirrhosis cases are related to alcohol, a seven-year national study of more than 100 million privately insured people has found.

4 May 2018

Study: HCV-exposed infants not adequately screened, despite increased prevalence

Due to the opioid epidemic, hepatitis C virus is increasing among pregnant women, resulting in a greater risk of perinatal transmission and HCV infection among children.

2 May 2018

New studies related to causes of liver degradation and possible treatments

A treatment gap remains for many conditions involving damage to the liver, the body's main organ for removing toxins, among other functions. The Experimental Biology 2018 meeting (EB 2018) will feature important research announcements related to the causes of liver degradation and possible treatments.

23 Apr 2018

Cirrhosis News and Research

Latest Cirrhosis News and Research

Researchers focus on mechanisms involved in development of non-alcoholic fatty liver disease

Researchers develop inexpensive blood test to diagnose hepatitis B patients

Chemical compounds produced by gut bacteria could help spot early stages of liver disease

Coffee and the heart – four strong cups a day is beneficial finds study

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

Ultrasound-based technology for assessing overweight adolescents with liver disease

Video consultations boost survival rates of liver disease patients, study finds

Research shows that treating cholestasis in father lowers risk of high blood pressure in son

Changes to the immune system remain even after recovery from HCV infection, shows study

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

Researchers gain new insights into hepatitis B virus

MiNA Therapeutics announces initial results from phase I trial of saRNA candidate in liver cancer patients

Researchers study effects of specific gut enterobacterium on body fat mass

New mathematical model holds potential to improve treatment for Hepatitis C infection

Scientists develop lab-based system to study mechanisms of common liver disease

Scientists find how immune system helps to clear HBV infection after treatment interruption

Key metabolites shed by gut bacteria can help protect from inflammation, study finds

Research shows prevalence, health-care utilization, and costs of alcohol-related cirrhosis

Study: HCV-exposed infants not adequately screened, despite increased prevalence

New studies related to causes of liver degradation and possible treatments

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Cirrhosis News and Research

Latest Cirrhosis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in